Baifeng Pharmaceutical

Liaoning Baifeng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical distribution and marketing services provider based in Shenyang, Liaoning Province. Listed on the National Equities Exchange and Quotations (NEEQ) in China, the company specializes in the wholesale and regional distribution of a wide range of medical products, including chemical drugs, biological preparations, and medical devices. Historically, the company operated a manufacturing arm, Liaoning Baifeng Biological Pharmaceutical, which was acquired by the South Korean pharmaceutical giant Daewoong Pharmaceutical in 2013 to produce cephalosporin antibiotics and liquid formulations. Currently, the company focuses on providing supply chain management and academic marketing services to hospitals and medical institutions across Northeast China. It maintains a comprehensive GSP-certified logistics network and partnerships with major domestic pharmaceutical manufacturers.